Phase I Trial of Maintenance Sorafenib after Allogeneic Hematopoietic Stem Cell Transplantation for Fms-like Tyrosine Kinase 3 Internal Tandem Duplication Acute Myeloid LeukemiaYi‐Bin Chen, Robert J. Soiffer, Corey Cutler et al.|Biology of Blood and Marrow Transplantation|2014Cited by 234
Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversityZachariah DeFilipp, Yi‐Bin Chen, Marcel R.M. van den Brink et al.|Blood Advances|2018Cited by 206